CP-003
N/A
Report date: 2024/12/25 20:00:50
Base Information
Drug NameCP-003
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesCaelus Health
China Registration ClassN/A
Develop Information
Active CompaniesThe University Of Hong Kong
Inactive CompaniesJohnson & Johnson Innovation LtdCaelus Health
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A